Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ahmet Aydin

Concepts (145)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
7
2022
158
3.060
Why?
Penile Neoplasms
6
2021
44
3.000
Why?
Carcinoma, Squamous Cell
5
2021
326
1.930
Why?
Carcinoma, Transitional Cell
3
2022
51
1.540
Why?
Kidney Neoplasms
5
2021
174
1.510
Why?
Prostatic Neoplasms
3
2020
384
1.510
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
76
1.430
Why?
Carcinoma, Renal Cell
4
2021
101
1.000
Why?
Immunotherapy
6
2021
235
0.870
Why?
Pheochromocytoma
1
2023
36
0.860
Why?
Adrenal Gland Neoplasms
1
2023
51
0.850
Why?
Urothelium
1
2021
17
0.730
Why?
BCG Vaccine
2
2020
16
0.710
Why?
Diskectomy
1
2020
12
0.700
Why?
Intervertebral Disc Displacement
1
2020
12
0.700
Why?
Neoadjuvant Therapy
5
2022
120
0.700
Why?
Indocyanine Green
1
2020
34
0.700
Why?
Cancer Vaccines
1
2021
80
0.690
Why?
Ubiquitin Thiolesterase
2
2021
17
0.680
Why?
CD8-Positive T-Lymphocytes
1
2021
125
0.680
Why?
Adjuvants, Immunologic
1
2020
51
0.660
Why?
Endoscopy
1
2020
119
0.660
Why?
Patient Readmission
1
2021
227
0.650
Why?
Anesthesia, Local
1
2019
16
0.650
Why?
Male
25
2021
25910
0.640
Why?
Edetic Acid
1
2019
14
0.640
Why?
Tumor Suppressor Proteins
2
2021
128
0.640
Why?
Immunotherapy, Adoptive
1
2021
163
0.640
Why?
Testicular Neoplasms
4
2021
45
0.630
Why?
Ureteral Neoplasms
1
2019
11
0.630
Why?
Prostate-Specific Antigen
1
2019
44
0.630
Why?
Papillomavirus Infections
1
2021
168
0.620
Why?
Oligopeptides
1
2019
95
0.600
Why?
Neoplasm Recurrence, Local
4
2021
629
0.560
Why?
Humans
31
2023
50509
0.550
Why?
Cystectomy
3
2022
49
0.550
Why?
Retrospective Studies
11
2022
6263
0.530
Why?
Arteriovenous Fistula
1
2016
30
0.520
Why?
Middle Aged
13
2021
12614
0.500
Why?
Aged
12
2021
9743
0.490
Why?
Neoplasms, Germ Cell and Embryonal
3
2021
23
0.470
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2022
1000
0.450
Why?
Lymphatic Metastasis
4
2021
222
0.420
Why?
Neoplasm Grading
4
2020
122
0.400
Why?
Female
15
2023
27086
0.380
Why?
Neoplasm Invasiveness
3
2022
269
0.380
Why?
Treatment Outcome
8
2022
5285
0.360
Why?
Tumor Microenvironment
3
2021
222
0.350
Why?
Lymph Nodes
2
2021
257
0.310
Why?
Adult
9
2023
13583
0.270
Why?
Prognosis
3
2020
1978
0.250
Why?
Neoplasm Metastasis
3
2021
232
0.230
Why?
Postoperative Complications
3
2021
1033
0.230
Why?
Quality of Life
2
2020
852
0.220
Why?
Adrenalectomy
1
2023
35
0.220
Why?
Adrenal Glands
1
2023
40
0.220
Why?
Neoplasm Staging
3
2021
746
0.200
Why?
Aged, 80 and over
2
2021
3228
0.200
Why?
Deoxycytidine
1
2022
30
0.200
Why?
Retroperitoneal Space
2
2021
27
0.200
Why?
Cohort Studies
3
2021
1452
0.190
Why?
Muscles
1
2022
104
0.190
Why?
Mycobacterium bovis
1
2021
11
0.180
Why?
Antigens, Differentiation, Myelomonocytic
1
2021
39
0.180
Why?
Lymph Node Excision
2
2021
131
0.180
Why?
Aftercare
1
2021
72
0.180
Why?
T-Lymphocytes
2
2020
325
0.180
Why?
Teratoma
1
2021
22
0.180
Why?
Interleukin-2
1
2021
71
0.180
Why?
Diskectomy, Percutaneous
1
2020
1
0.180
Why?
Reference Standards
1
2020
52
0.180
Why?
Tomography, Emission-Computed
1
2020
53
0.180
Why?
Fluorouracil
1
2020
58
0.180
Why?
Lymphocyte Activation
1
2021
164
0.170
Why?
Cisplatin
1
2022
286
0.170
Why?
Microscopy
1
2020
59
0.170
Why?
Recurrence
2
2019
659
0.170
Why?
Carcinoma in Situ
1
2020
73
0.170
Why?
Antigens, CD
1
2021
222
0.170
Why?
Hemostasis, Endoscopic
1
2019
5
0.170
Why?
Sentinel Lymph Node Biopsy
1
2020
118
0.170
Why?
Lumbar Vertebrae
1
2020
102
0.160
Why?
Survival Rate
2
2019
909
0.160
Why?
Gallium Isotopes
1
2019
2
0.160
Why?
Gallium Radioisotopes
1
2019
10
0.160
Why?
Kidney Pelvis
1
2019
17
0.160
Why?
Patient Discharge
1
2021
321
0.160
Why?
Gastrointestinal Hemorrhage
1
2019
80
0.160
Why?
Disease-Free Survival
1
2020
444
0.160
Why?
Feasibility Studies
1
2020
391
0.150
Why?
Genomics
1
2020
279
0.150
Why?
Papillomavirus Vaccines
1
2019
67
0.150
Why?
Urologic Neoplasms
1
2018
12
0.150
Why?
Ureteral Obstruction
1
2019
61
0.150
Why?
Carcinoma, Papillary
1
2018
47
0.150
Why?
Antineoplastic Agents
3
2020
1172
0.140
Why?
Genetic Predisposition to Disease
1
2020
511
0.140
Why?
Cells, Cultured
1
2021
1571
0.140
Why?
Biopsy
1
2019
588
0.140
Why?
Cell Proliferation
1
2021
985
0.140
Why?
Anticoagulants
1
2019
256
0.130
Why?
Renal Artery
1
2016
33
0.130
Why?
Gene Expression Regulation, Neoplastic
1
2020
833
0.130
Why?
Nephrectomy
1
2016
81
0.130
Why?
Time Factors
2
2020
2934
0.130
Why?
Hospitalization
1
2019
675
0.120
Why?
Urinary Tract Infections
1
2015
51
0.120
Why?
Laparoscopy
1
2016
173
0.110
Why?
Prospective Studies
1
2020
2378
0.110
Why?
Risk Factors
2
2019
3724
0.110
Why?
Kidney Failure, Chronic
1
2015
201
0.100
Why?
Kidney Transplantation
1
2015
189
0.100
Why?
Chemotherapy, Adjuvant
2
2020
121
0.080
Why?
Kaplan-Meier Estimate
2
2021
464
0.080
Why?
Follow-Up Studies
3
2020
2241
0.080
Why?
Survival Analysis
2
2021
661
0.070
Why?
Turkey
2
2019
17
0.070
Why?
T-Lymphocyte Subsets
1
2021
39
0.040
Why?
Immune System
1
2021
43
0.040
Why?
Administration, Topical
1
2020
57
0.040
Why?
Forkhead Transcription Factors
1
2021
110
0.040
Why?
Urinary Bladder
1
2020
93
0.040
Why?
Peptic Ulcer Hemorrhage
1
2019
5
0.040
Why?
Duodenal Ulcer
1
2019
13
0.040
Why?
Stomach Ulcer
1
2019
8
0.040
Why?
Patient Selection
1
2020
259
0.040
Why?
Treatment Failure
1
2019
118
0.040
Why?
Macrophages
1
2021
364
0.040
Why?
Socioeconomic Factors
1
2020
591
0.040
Why?
Health Facilities
1
2017
40
0.040
Why?
Oncolytic Virotherapy
1
2017
18
0.040
Why?
Combined Modality Therapy
1
2018
641
0.030
Why?
Adolescent
2
2019
6447
0.030
Why?
Mutation
1
2021
1281
0.030
Why?
Clinical Trials as Topic
1
2017
486
0.030
Why?
Child
2
2019
6910
0.030
Why?
Registries
1
2017
563
0.030
Why?
Graft Survival
1
2015
159
0.030
Why?
Cytokines
1
2017
606
0.030
Why?
Antibodies, Monoclonal
1
2017
462
0.030
Why?
Mice
1
2020
5687
0.020
Why?
Child, Preschool
1
2019
3944
0.020
Why?
Young Adult
1
2018
4106
0.020
Why?
United States
1
2017
4958
0.020
Why?
Animals
1
2020
13124
0.020
Why?
Aydin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description